OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status
Thomas B. Casale, Ana M. Giménez‐Arnau, Jonathan A. Bernstein, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 11, pp. 2573-2588
Open Access | Times Cited: 17
Thomas B. Casale, Ana M. Giménez‐Arnau, Jonathan A. Bernstein, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 11, pp. 2573-2588
Open Access | Times Cited: 17
Showing 17 citing articles:
Chronic urticaria: unmet needs, emerging drugs, and new perspectives on personalised treatment
Torsten Zuberbier, Luís Felipe Ensina, Ana M. Giménez‐Arnau, et al.
The Lancet (2024) Vol. 404, Iss. 10450, pp. 393-404
Open Access | Times Cited: 20
Torsten Zuberbier, Luís Felipe Ensina, Ana M. Giménez‐Arnau, et al.
The Lancet (2024) Vol. 404, Iss. 10450, pp. 393-404
Open Access | Times Cited: 20
Therapies for Chronic Spontaneous Urticaria: Present and Future Developments
Riccardo Asero, Paolo Calzari, Silvia Vaienti, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 11, pp. 1499-1499
Open Access | Times Cited: 4
Riccardo Asero, Paolo Calzari, Silvia Vaienti, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 11, pp. 1499-1499
Open Access | Times Cited: 4
BIOLOGICS IN THE TREATMENT OF CHRONIC SPONTANEOUS URTICARIA: MECHANISMS, EFFICACY AND FUTURE PROSPECTS
João Freitas, Bruna Andressa dos Santos Oliveira, Gabriella Almeida Santos de Santana, et al.
International Journal of Health Science (2025) Vol. 5, Iss. 4, pp. 1-6
Closed Access
João Freitas, Bruna Andressa dos Santos Oliveira, Gabriella Almeida Santos de Santana, et al.
International Journal of Health Science (2025) Vol. 5, Iss. 4, pp. 1-6
Closed Access
Comparação da eficácia em longo prazo e da relação custo‐eficácia de omalizumabe nas doses de 150 mg e 300 mg em pacientes com urticária crônica espontânea
Fikriye Kalkan, Sait Yeşillik, Fevzi Demirel, et al.
(2025) Vol. 100, Iss. 1, pp. 31-37
Open Access
Fikriye Kalkan, Sait Yeşillik, Fevzi Demirel, et al.
(2025) Vol. 100, Iss. 1, pp. 31-37
Open Access
Eosinophil-Driven vs. Eosinophil-Associated Severe Asthma: Practical Implications for Target Treatment
Valentina D’Aiuto, Ilaria Mormile, Francescopaolo Granata, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1729-1729
Open Access
Valentina D’Aiuto, Ilaria Mormile, Francescopaolo Granata, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1729-1729
Open Access
Clinical phenotypes and biomarkers in chronic urticaria
Aray Batyrbayeva, Zhanat Ispayeva, M. Pashimov, et al.
Clinica Chimica Acta (2025) Vol. 571, pp. 120233-120233
Closed Access
Aray Batyrbayeva, Zhanat Ispayeva, M. Pashimov, et al.
Clinica Chimica Acta (2025) Vol. 571, pp. 120233-120233
Closed Access
Type 2 Inflammation and Its Role in Dermatologic Diseases
Raj Chovatiya, Jason E. Hawkes, Douglas DiRuggiero, et al.
International Journal of Dermatology (2025)
Open Access
Raj Chovatiya, Jason E. Hawkes, Douglas DiRuggiero, et al.
International Journal of Dermatology (2025)
Open Access
Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Alcivan Nunes Vieira, Ana Carolina Ventura de Santana de Jesus, Anelise Poluboiarinov Cappellaro, et al.
Clinical Drug Investigation (2025)
Closed Access
Alcivan Nunes Vieira, Ana Carolina Ventura de Santana de Jesus, Anelise Poluboiarinov Cappellaro, et al.
Clinical Drug Investigation (2025)
Closed Access
Quality of life, sleep, and psychological well-being in chronic spontaneous urticaria patients receiving omalizumab: a case–control study
Mustafa Esen, Abdullah Demirbaş, Esin Diremsizoğlu
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Closed Access
Mustafa Esen, Abdullah Demirbaş, Esin Diremsizoğlu
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Closed Access
Characteristics of patients with chronic spontaneous urticaria who are late-responders to omalizumab
Giselle Mosnaim, Thomas B. Casale, Michael Holden, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 9, pp. 2537-2539
Open Access | Times Cited: 2
Giselle Mosnaim, Thomas B. Casale, Michael Holden, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 9, pp. 2537-2539
Open Access | Times Cited: 2
Mechanisms of histamine release from mast cells beyond the high affinity IgE receptor in severe chronic spontaneous urticaria
Riccardo Asero
Immunology Letters (2023) Vol. 265, pp. 1-4
Closed Access | Times Cited: 2
Riccardo Asero
Immunology Letters (2023) Vol. 265, pp. 1-4
Closed Access | Times Cited: 2
The psychoemotional impact of biological therapy on dermatological patients
Dan Vâță, Diana-Elena Stanciu, Bogdan-Marian Tarcău, et al.
Bulletin of Integrative Psychiatry (2024) Vol. 100, Iss. 1, pp. 129-135
Open Access
Dan Vâță, Diana-Elena Stanciu, Bogdan-Marian Tarcău, et al.
Bulletin of Integrative Psychiatry (2024) Vol. 100, Iss. 1, pp. 129-135
Open Access
A comprehensive analysis on the safety of two biologics dupilumab and omalizumab
Yu Xiao, W.H. Yang, M M Wang
Frontiers in Medicine (2024) Vol. 11
Open Access
Yu Xiao, W.H. Yang, M M Wang
Frontiers in Medicine (2024) Vol. 11
Open Access
Comparison of long term efficacy and cost-effectiveness of omalizumab in 150 mg and 300 mg doses in patients with chronic spontaneous urticaria
Fikriye Kalkan, Sait Yeşillik, Fevzi Demirel, et al.
Anais Brasileiros de Dermatologia (2024)
Open Access
Fikriye Kalkan, Sait Yeşillik, Fevzi Demirel, et al.
Anais Brasileiros de Dermatologia (2024)
Open Access
Cost-effective omalizumab dosage for chronic urticaria: a systematic review and network meta-analysis
Amin Tajerian, Ali Pourvali, Maryam Khoshkhui, et al.
Archives of Dermatological Research (2024) Vol. 317, Iss. 1
Closed Access
Amin Tajerian, Ali Pourvali, Maryam Khoshkhui, et al.
Archives of Dermatological Research (2024) Vol. 317, Iss. 1
Closed Access
Structure and Function of IgE
Jovanny Guillen, Peter M. Bowers, Ali A. Zarrin
Elsevier eBooks (2024)
Closed Access
Jovanny Guillen, Peter M. Bowers, Ali A. Zarrin
Elsevier eBooks (2024)
Closed Access
